Vertex Pharmaceuticals: ToolGen files patent infringement lawsuit against Vertex Pharma in UK for genome editing therapy CASGEVY
ToolGen, Inc. a global leader in genome editing technology, announced that it has filed a patent infringement lawsuit in the United Kingdom against Vertex Pharmaceuticals and its commercial manufacturing partners, Lonza and
Read full article »
Vertex Pharmaceuticals is a Massachusetts-based biotechnology company that researches and develops medicines for the treatment of cystic fibrosis and sickle cell diseases.
Read more